Related Experiment Video
Updated: Jan 11, 2026

Transoral Endoscopic Thyroidectomy Vestibular Approach for Thyroid Lobectomy
Published on: May 12, 2023
Advancing the Therapeutic Frontier in Thyroid Eye Disease
Seyed Omid Mohammadi1, Coby Ray2
1School of Medicine, Texas Christian University, Fort Worth, TX, USA.
None:
Thyroid eye disease (TED), also known as Graves' orbitopathy, is driven by autoimmune processes that lead to orbital inflammation, oedema and potential vision loss. Traditional management includes high-dose intravenous corticosteroids, orbital radiotherapy and surgery. However, newer therapies, notably teprotumumab (a monoclonal antibody against the insulin-like growth factor I receptor), offer targeted immunomodulation with promising outcomes in reducing proptosis and improving symptoms. The future of TED treatment lies in further research on biologics, personalized approaches and continued multidisciplinary collaboration to optimize patient care.
More Related Videos
03:55Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Glaucoma: Overview